AMA recently voted to advance the development of a comprehensive strategy that allows more consistent coverage of genomic and genetic tests and precision medicine, a move intended to enhance patient access to useful new genetic tests and therapeutics that have clinical impact.
“Precision medicine tests, technologies and therapeutics are increasingly being adopted into clinical practice as evidence of their effectiveness grows,” AMA Board Member William E. Kobler, MD, said in a press release. “However, many patients do not have access to precision medicine because most public
Uncategorized